SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HEB, Hemispherx Biopharma (AMEX)NEW
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Marty who wrote (497)10/23/1998 2:17:00 PM
From: Gerald Walls  Read Replies (3) of 857
 
I appreciate that they don't "prove" anything, one way or the other, about the drug but, nevertheless, they are certainly remarkable and not without value. I hope the FDA seriously takes such episodes into consideration for early approval, especially since there does not seem to be any substantive downside for the patients.

The FDA doesn't work that way. Look at the vitamin industry. They can't make a single claim on their bottles that haven't been proven or the FDA nails them. And this is just for preventative applications, let alone a claim to actually cure a disease.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News